Dr. Nada S. Al-Qadheeb
Director of Global Health Systems and Strategic Reform
Dr. Al-Qadheeb is an Executive Leader in Pharmaceutical Governance & Health System Strategy in the Kingdom of Saudi Arabia. She believes healthcare systems do not transform through incremental change. They transform through structured governance, disciplined execution, and measurable accountability.
After completing advanced Critical Care Pharmacy training at the Johns Hopkins Hospital and Northeastern University, Dr. Al-Qadheeb developed a unique ability to bridge high-acuity frontline practice with executive-level system leadership. She continues to maintain active clinical engagement while shaping institutional governance and performance standards at scale.
A senior healthcare executive leader, Dr. Al-Qadheeb specializes in pharmaceutical governance, system-scale medication optimization, and strategic health transformation. In her current executive role, she has led pharmaceutical strategy across a large integrated health network — spanning 22 hospitals and more than 120 primary healthcare centers — overseeing formulary governance, professional development, medication stewardship programs, enterprise policy alignment, digital integration, and workforce capability development.
In parallel, she serves as the Director of Human Research Protection Program (HRPP) overseeing research governance, regulatory compliance and human subject protection standards. Most recently she directed the development of the Pharmaceutical Care and Formulary Strategic Plan (2026–2030), building upon an integrated pharmaceutical strategy initiated in 2020. The framework standardizes medication practices, strengthens stewardship oversight in critical care and antimicrobial use, embeds data-driven performance dashboards, and supports digital and AI-enabled optimization aligned with national health transformation priorities.
She demonstrated the global scalability of high-reliability training standards by establishing the first American Society of Health System Pharmacy-accredited residency program outside the United States.
Dr. Al-Qadheeb excels in disciplined execution, strategic clarity, and scalable results for organizations seeking to strengthen medication governance, redesign formulary systems, institutionalize stewardship programs, or align pharmaceutical services with large-scale transformation initiatives.
Academic & Institutional Leadership
Chief of Clinical Pharmacy, Kingdom of Saudi Arabia, Eastern Health Cluster (EHC), overseeing clinical governance and strategy for a multi-hospital network.
Consultant Critical Care Pharmacist, King Fahad Specialist Hospital – Dammam.
Adjunct Associate Professor, Imam Abdulrahman Bin Faisal University.
Dual Fellow Distinction: Inducted as a Fellow of the American College of Clinical Pharmacy (FCCP) and the American College of Critical Care Medicine (FCCM).
Clinical & Operational Expertise
Board Certified Critical Care Pharmacist (BCCCP) with advanced specialization in sedation, analgesia, and delirium management.
Completed a Critical Care Pharmacy Fellowship at Northeastern University/Tufts Medical Center and a PGY2 Critical Care Residency at The Johns Hopkins Hospital.
Former Consultant at King Faisal Specialist Hospital & Research Centre, where she authored the roadmap for international residency accreditation.
National Service & Advocacy
Established first United States organization accredited pharmacy residency program Overseas.
Lead author and director of the Pharmaceutical Care and Formulary Strategic Plan (2026–2030), a cornerstone document for the Eastern Health Cluster (EHC) that serves as a blueprint for standardizing medication practice across 22 hospitals and 120+ primary care centers.
Maintains a high-level advocacy role through induction as a Fellow of the American College of Clinical Pharmacy (FCCP) and a Fellow of the American College of Critical Care Medicine (FCCM), representing Saudi clinical excellence on the global stage.
Serves on the Critical Care Editorial Advisory Panel for Wolters Kluwer, ensuring evidence-based clinical information is represented in international references.
